107 related articles for article (PubMed ID: 26482281)
1. Aldehyde dehydrogenase induction in arsenic-exposed rat bladder epithelium.
Huang YC; Yu HS; Chai CY
Exp Toxicol Pathol; 2016 Jan; 68(1):61-8. PubMed ID: 26482281
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of annexin a1 induced by terephthalic acid calculi in rat bladder cancer.
Cui L; Wang Y; Shi Y; Zhang Z; Xia Y; Sun H; Wang S; Chen J; Zhang W; Lu Q; Song L; Wei Q; Zhang R; Wang X
Proteomics; 2007 Nov; 7(22):4192-202. PubMed ID: 17994624
[TBL] [Abstract][Full Text] [Related]
3. Arsenic and urinary bladder cell proliferation.
Luster MI; Simeonova PP
Toxicol Appl Pharmacol; 2004 Aug; 198(3):419-23. PubMed ID: 15276422
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in taiwan.
Chen CH; Chiou HY; Hsueh YM; Chen CJ; Yu HJ; Pu YS
J Urol; 2009 Feb; 181(2):547-52; discussion 553. PubMed ID: 19084863
[TBL] [Abstract][Full Text] [Related]
5. Arsenic treatment increase Aurora-A overexpression through E2F1 activation in bladder cells.
Kao YT; Wu CH; Wu SY; Lan SH; Liu HS; Tseng YS
BMC Cancer; 2017 Apr; 17(1):277. PubMed ID: 28420331
[TBL] [Abstract][Full Text] [Related]
6. Effects of DNMT and MEK inhibitors on the expression of RECK, MMP-9, -2, uPA and VEGF in response to arsenite stimulation in human uroepithelial cells.
Huang YC; Hung WC; Chen WT; Yu HS; Chai CY
Toxicol Lett; 2011 Feb; 201(1):62-71. PubMed ID: 21167264
[TBL] [Abstract][Full Text] [Related]
7. MiADMSA ameliorate arsenic induced urinary bladder carcinogenesis in vivo and in vitro.
Sathua K; Srivastava S; Flora SJS
Biomed Pharmacother; 2020 Aug; 128():110257. PubMed ID: 32474354
[TBL] [Abstract][Full Text] [Related]
8. Expression of WWOX and FHIT is downregulated by exposure to arsenite in human uroepithelial cells.
Huang YC; Hung WC; Chen WT; Yu HS; Chai CY
Toxicol Lett; 2013 Jul; 220(2):118-25. PubMed ID: 23618899
[TBL] [Abstract][Full Text] [Related]
9. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.
Huang YK; Huang YL; Hsueh YM; Yang MH; Wu MM; Chen SY; Hsu LI; Chen CJ
Cancer Causes Control; 2008 Oct; 19(8):829-39. PubMed ID: 18351295
[TBL] [Abstract][Full Text] [Related]
10. Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan.
Tan LB; Chen KT; Guo HR
BJU Int; 2008 Jul; 102(1):48-54. PubMed ID: 18445081
[TBL] [Abstract][Full Text] [Related]
11. CHD4 plays a critical role in arsenite-induced oxidative damage in human urothelial carcinoma.
Chang SJ; Bin PJ; Luo CW; Chai CY
Pathol Res Pract; 2022 Dec; 240():154173. PubMed ID: 36306724
[TBL] [Abstract][Full Text] [Related]
12. Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma.
Tyan YC; Yang MH; Chen SC; Jong SB; Chen WC; Yang YH; Chung TW; Liao PC
Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2851-62. PubMed ID: 21913264
[TBL] [Abstract][Full Text] [Related]
13. Dietary administration of sodium arsenite to rats: relations between dose and urinary concentrations of methylated and thio-metabolites and effects on the rat urinary bladder epithelium.
Suzuki S; Arnold LL; Pennington KL; Chen B; Naranmandura H; Le XC; Cohen SM
Toxicol Appl Pharmacol; 2010 Apr; 244(2):99-105. PubMed ID: 20045014
[TBL] [Abstract][Full Text] [Related]
14. Aberrant β-catenin expression in urothelial carcinomas in blackfoot disease-endemic areas.
Chen YT; Wu CC; Liu XP; Chai CY
Kaohsiung J Med Sci; 2017 Jan; 33(1):11-16. PubMed ID: 28088268
[TBL] [Abstract][Full Text] [Related]
15. Changes in aldehyde dehydrogenase during rat urinary bladder carcinogenesis.
Campbell P; Irving CC; Lindahl R
Carcinogenesis; 1989 Nov; 10(11):2081-7. PubMed ID: 2805229
[TBL] [Abstract][Full Text] [Related]
16. Effects of MEK and DNMT inhibitors on arsenic-treated human uroepithelial cells in relation to Cyclin-D1 and p16.
Huang YC; Hung WC; Chen WT; Jiang WH; Yu HS; Chai CY
Toxicol Lett; 2011 Jan; 200(1-2):59-66. PubMed ID: 21040761
[TBL] [Abstract][Full Text] [Related]
17. Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan.
Yang CY; Chiu HF; Chang CC; Ho SC; Wu TN
Environ Res; 2005 May; 98(1):127-32. PubMed ID: 15721893
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of aldo-keto reductase 1C2 as a high-risk factor in bladder cancer.
Tai HL; Lin TS; Huang HH; Lin TY; Chou MC; Chiou SH; Chow KC
Oncol Rep; 2007 Feb; 17(2):305-11. PubMed ID: 17203165
[TBL] [Abstract][Full Text] [Related]
19. [Induction of urothelial carcinoma due to chronic arsenic ingestion? A occupational medicine-toxicological excursion].
Müller M; Böcher A; Buchter A
Urologe A; 2007 May; 46(5):511-2, 514-5. PubMed ID: 17216513
[TBL] [Abstract][Full Text] [Related]
20. Characterization of ADAM28 as a biomarker of bladder transitional cell carcinomas by urinary proteome analysis.
Yang MH; Chu PY; Chen SC; Chung TW; Chen WC; Tan LB; Kan WC; Wang HY; Su SB; Tyan YC
Biochem Biophys Res Commun; 2011 Aug; 411(4):714-20. PubMed ID: 21782798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
